Interacts (via PxIxIT motif, when phosphorylated on Thr-44) with PPP3CA. Not expressed in pancreatic duct cells (at protein level). Abundantly expressed in the pancreas and weakly expressed in the thyroid. Not expressed in pancreatic duct cells (at protein level). Abundantly expressed in the lymph node and weakly expressed in the stomach, trachea and bone marrow. May act as a prognostic marker of median survival time in pancreatic cancer patients. Intron retention.